Status:

UNKNOWN

The Effect of Individualized Intervention on the Quality of Bowel Preparation

Lead Sponsor:

Second Affiliated Hospital of Xi'an Jiaotong University

Conditions:

Bowel Preparation Solutions

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Colorectal cancer (CRC) is one of the most common malignant tumors in the clinic. Colonoscopy is an important means of screening, diagnosis and treatment of colorectal diseases. The accuracy of diagno...

Detailed Description

Colorectal cancer (CRC) is a malignant tumor originates from colorectal mucosa epithelium. It is one of the most common malignant tumors in the world. Incidence rate of lung cancer is second only to l...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Aged between 18-75
  • Patients with insufficient bowel preparation
  • Patients without cognitive and communication barriers
  • Informed consent, voluntary participation in the study Exclusion criteria:
  • 1\. Severe suppurative inflammation of anus and rectum 2. Severe acute enteritis and ischemic enteropathy 3. After partial colorectal resection 4. Peritonitis, intestinal perforation, extensive adhesion in the abdominal cavity and intestinal stenosis caused by various reasons 5. Large abdominal aneurysm, highly abnormal bowel flexion and late cancer with extensive intraperitoneal metastasis 6. Dysphagia or impaired swallowing reflex 7. Obvious gastroparesis or gastric outlet obstruction or intestinal obstruction 8. Severe chronic renal failure (creatinine clearance \< 30 ml / min) 9. Severe congestive heart failure (NYHA class III or IV) 10. Uncontrolled hypertension (systolic pressure \> 170 mm Hg, diastolic pressure \> 100 mm Hg) 11. Toxic colitis or megacolon 12. Disorder of water and electrolyte 13. Pregnancy or lactation 14. Mental patients 15. Failure to give informed consent

Exclusion

    Key Trial Info

    Start Date :

    July 1 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 30 2021

    Estimated Enrollment :

    408 Patients enrolled

    Trial Details

    Trial ID

    NCT04446195

    Start Date

    July 1 2020

    End Date

    March 30 2021

    Last Update

    July 7 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The second affiliated hospital of xi'an jiaotong university

    Xi'an, Shaanxi, China, 710004